InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

CJ

Chernett Jorey

OWNER 10PCT

Oncology Institute, Inc.Neuronetics, Inc.Airsculpt Technologies, Inc.Starling Oncology, Inc.

Cumul. flow

0

Total declarations

0

Companies

€6m

▲ Purchases (35 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

35

Disclosed sells

0

T+90 hit rate

75%

T+90 mean return

+50.4%

Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the detailed record of transactions filed by Chernett Jorey. Insider active across 4 companies, notably Oncology Institute, Inc.. In total, 35 filings have been logged. Breakdown: 35 buys · 0 sell. Total volume traded: €6.4m. Activity tracked since 3 March 2026. The latest transaction was disclosed on 14 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Chernett Jorey

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Oncology Institute, Inc. (US)Neuronetics, Inc. (US)Airsculpt Technologies, Inc. (US)Starling Oncology, Inc. (US)

Declarations35 total

▲

10% OwnerExecutives14 Aug 2026Starling Oncology, Inc.

$78,48017SEC ↗

12,000 shares@ US$6.54100.0% of flowCommon StockSEC:0000921895-26-002203:0

Canonical exit: 12 Nov 2026 (T+90)

▲

10% OwnerExecutives14 Aug 2026Neuronetics, Inc.

$44,24024SEC ↗

14,000 shares@ US$3.160.019% mcap1.3% of flowCommon StockSEC:0000921895-26-002204:0

Canonical exit: 12 Nov 2026 (T+90)

▲

10% OwnerExecutives21 Jul 2026Oncology Institute, Inc.

$94,86015SEC ↗

18,000 shares@ US$5.275.0% of flowCommon StockSEC:0000921895-26-001852:0

Canonical exit: 19 Oct 2026 (T+90)

▲

10% OwnerExecutives14 Jul 2026Neuronetics, Inc.

$62,30025SEC ↗

35,000 shares@ US$1.780.051% mcap1.9% of flowCommon StockSEC:0000921895-26-001811:0

Canonical exit: 12 Oct 2026 (T+90)

▲

10% OwnerExecutives10 Jul 2026Oncology Institute, Inc.

$87,75016SEC ↗

15,000 shares@ US$5.854.8% of flowCommon StockSEC:0000921895-26-001798:0

Canonical exit: 8 Oct 2026 (T+90)

▲

10% OwnerExecutives23 Jun 2026Oncology Institute, Inc.

18,000 sharesCommon StockSEC:0000921895-26-001657:0

Canonical exit: 21 Sept 2026 (T+90)

▲

10% OwnerExecutives4 Jun 2026Oncology Institute, Inc.

$57,00016SEC ↗

12,000 shares@ US$4.7526.7% of flowCommon StockSEC:0000921895-26-001564:0

Canonical exit: 2 Sept 2026 (T+90)

▲

10% OwnerExecutives19 May 2026Oncology Institute, Inc.

$20,2507SEC ↗

5,000 shares@ US$4.0512.9% of flowCommon StockSEC:0000921895-26-001466:0

Canonical exit: 17 Aug 2026 (T+90)

▲

10% OwnerExecutives20 May 2026Oncology Institute, Inc.

$136,34516SEC ↗

33,500 shares@ US$4.0787.1% of flowCommon StockSEC:0000921895-26-001466:1

Canonical exit: 18 Aug 2026 (T+90)

▲

10% OwnerExecutives20 Apr 2026Neuronetics, Inc.

$158,00025SEC ↗

100,000 shares@ US$1.580.14% mcap51.0% of flowCommon StockSEC:0000921895-26-001056:0

Canonical exit: 19 Jul 2026 (T+90)

▲

10% OwnerExecutives21 Apr 2026Neuronetics, Inc.

$151,00027SEC ↗

100,000 shares@ US$1.510.14% mcap49.0% of flowCommon StockSEC:0000921895-26-001056:1

Canonical exit: 20 Jul 2026 (T+90)

▲

10% OwnerExecutives17 Apr 2026Airsculpt Technologies, Inc.

$101,60023SEC ↗

40,000 shares@ US$2.540.031% mcap66.2% of flowCommon StockSEC:0000921895-26-001030:0

Canonical exit: 16 Jul 2026 (T+90)

▲

10% OwnerExecutives14 Apr 2026Airsculpt Technologies, Inc.

$52,00015SEC ↗

20,000 shares@ US$2.600.016% mcap33.8% of flowCommon StockSEC:0000921895-26-000989:0

Canonical exit: 13 Jul 2026 (T+90)

▲

10% OwnerExecutives9 Apr 2026Oncology Institute, Inc.

$62,00011SEC ↗

20,000 shares@ US$3.1022.4% of flowCommon StockSEC:0000921895-26-000958:0

Canonical exit: 8 Jul 2026 (T+90)

▲

10% OwnerExecutives7 Apr 2026Airsculpt Technologies, Inc.

$175,80014SEC ↗

60,000 shares@ US$2.9353.6% of flowCommon StockSEC:0000921895-26-000944:0

Canonical exit: 6 Jul 2026 (T+90)

▲

10% OwnerExecutives3 Apr 2026Airsculpt Technologies, Inc.

$253,80013SEC ↗

90,000 shares@ US$2.8243.9% of flowCommon StockSEC:0000921895-26-000915:0

Canonical exit: 2 Jul 2026 (T+90)

▲

Executives30 Mar 2026Neuronetics, Inc.

$481,80313SEC ↗

385,442 shares@ US$1.2529.6% of flowCommon StockSEC:0000921895-26-000835:0

Canonical exit: 28 Jun 2026 (T+90)

▲

Executives27 Mar 2026Oncology Institute, Inc.

$81,19011SEC ↗

27,429 shares@ US$2.969.0% of flowCommon StockSEC:0000921895-26-000823:0

Canonical exit: 25 Jun 2026 (T+90)

▲

Executives27 Mar 2026Neuronetics, Inc.

$675,00012SEC ↗

500,000 shares@ US$1.3541.2% of flowCommon StockSEC:0000921895-26-000822:0

Canonical exit: 25 Jun 2026 (T+90)

▲

Executives26 Mar 2026Oncology Institute, Inc.

$157,50010SEC ↗

50,000 shares@ US$3.1517.5% of flowCommon StockSEC:0000921895-26-000814:0

Canonical exit: 24 Jun 2026 (T+90)

▲

Executives25 Mar 2026Neuronetics, Inc.

$175,0007SEC ↗

125,000 shares@ US$1.4010.6% of flowCommon StockSEC:0000921895-26-000813:0

Canonical exit: 23 Jun 2026 (T+90)

▲

Executives23 Mar 2026Airsculpt Technologies, Inc.

$145,5008SEC ↗

50,000 shares@ US$2.9120.1% of flowCommon StockSEC:0000921895-26-000802:0

Canonical exit: 21 Jun 2026 (T+90)

▲

Executives24 Mar 2026Oncology Institute, Inc.

$388,75010SEC ↗

125,000 shares@ US$3.1143.0% of flowCommon StockSEC:0000921895-26-000796:0

Canonical exit: 22 Jun 2026 (T+90)

▲

Executives20 Mar 2026Neuronetics, Inc.

$238,9569SEC ↗

169,472 shares@ US$1.418.8% of flowCommon StockSEC:0001193805-26-000308:0

Canonical exit: 18 Jun 2026 (T+90)

▲

Executives20 Mar 2026Airsculpt Technologies, Inc.

$110,8009SEC ↗

40,000 shares@ US$2.7710.6% of flowCommon StockSEC:0001193805-26-000307:0

Canonical exit: 18 Jun 2026 (T+90)

25 of 35 declarations

About Chernett Jorey

Chernett Jorey is a declarant and a 10% Owner at Airsculpt Technologies, Inc., Oncology Institute, Inc. and Neuronetics, Inc. The 32 filings on record cover acquisitions from 2026-03-04 to 2026-07-15, with 6189422 EUR of buys and 0 EUR of sells in the sampled filings.